← All stocks

Passage BIO, Inc.

PASG Net buying
CIK 0001787297 #5149 in the set updated 17 Sep 2026
Bought (12 mo)
$206.10K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$113.18K
$0.00 on a plan · $113.18K straight out of an exercise
Sold at will
$0.00
0 of 2 sales
Net
+$92.92K
+$206.10K against sales at will

By person

4 insiders · 3 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Lynx1 Capital Management LP entity
10% owner
$206.10K (1)
+$206.10K
673,759
$2.77M
Chou William
PRESIDENT AND CEO
$75.16K (1) scheduled
−$75.16K
6,524
$26.86K
+987.3%
Borthwick Kathleen
CFO
$38.02K (1) scheduled
−$38.02K
5,402
$22.24K
ORBIMED ADVISORS LLC entity
10% owner
6,066,343
$24.98M
−22.8%

No percentages here. This company's share count has moved by a factor of 19.6 over the window, from 3,178,710 to 62,148,274 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Lynx1 Capital Management LP
25 Jun 2026
10% owner
Buy indirect
50,055
$4.12
$206.10K
Borthwick Kathleen
8 Jan 2026
CFO
Sold after exercise
2,062
$18.44
$38.02K
Chou William
8 Jan 2026
PRESIDENT AND CEO
Sold after exercise
4,076
$18.44
$75.16K

What was left out

Form 4 filings counted 13
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 2
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 15,000
History held since 2 Mar 2020